Starpharma (SPHRY) Stock Chart & Stock Price History $0.96 +0.21 (+27.51%) As of 10:51 AM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock Starpharma Stock Price Performance The Starpharma (SPHRY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 66.59%, with a year-to-date return of 48.64%. In the past month, the stock has increased 52.52%, reflecting recent market activity. As of the latest close, Starpharma traded at $0.75 with a market cap of $31.36 million and volume of 787 shares. Five years ago, the stock traded at $7.43, representing a 87.13% decrease over that period. At the time, it had a market cap of $292.83 million and a volume of 750 shares. Receive SPHRY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Starpharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+46.23%1 Month PerformanceN/A3 Month PerformanceN/AYear-To-Date Performance+48.64%1 Year Performance+66.59%5 Year Performance-87.13% SPHRY Stock Chart for Wednesday, August, 13, 2025 SPHRY Chart by TradingView Starpharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/12/2025$0.72$0.75+4.69%$0.75$0.71787 shs$31.36 million08/11/2025$0.65$0.72+9.54%$0.72$0.67500 shs$29.96 million08/08/2025$0.65$0.65$0.65$0.6597 shs$27.35 million08/07/2025$0.65$0.65$0.65$0.6597 shs$27.35 million08/06/2025$0.65$0.65$0.65$0.6597 shs$27.35 million08/05/2025$0.65$0.65$0.65$0.6597 shs$27.35 million08/04/2025$0.65$0.65$0.65$0.6597 shs$27.35 million07/23/2025$0.65$0.65$0.65$0.652,100 shs$27.35 million07/22/2025$0.71$0.65-8.31%$0.65$0.652,100 shs$27.35 million07/21/2025$0.71$0.71$0.71$0.60450 shs$29.83 million Get the Latest News and Ratings for SPHRY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Starpharma and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$0.67$0.71+6.13%$0.71$0.60450 shs$29.83 million07/17/2025$0.67$0.67$0.67$0.67100 shs$28.10 million07/16/2025$0.67$0.67$0.67$0.67100 shs$28.10 million07/15/2025$0.67$0.67$0.67$0.67100 shs$28.10 million07/14/2025$0.63$0.67+7.19%$0.67$0.67100 shs$28.10 million Related Companies CHRS Stock Chart COYA Stock Chart OBIO Stock Chart ZURA Stock Chart HLVX Stock Chart ANIX Stock Chart PRE Stock Chart ZNTL Stock Chart PLRX Stock Chart TCRX Stock Chart Receive SPHRY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Starpharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:SPHRY) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Starpharma Holdings Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Starpharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access